Progesterone Receptor Positive (PR+) breast cancer is a distinct biological subtype of hormone receptor positive breast cancer. This type of cancer grows in response to progesterone, a hormone that is ...
News-Medical.Net on MSN
Progesterone mimic plus anti-estrogen treatment slows tumor growth in breast cancer patients
A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-estrogen ...
A phase I/II trial of palbociclib, pembrolizumab, and endocrine therapy for patients with HR+/HER2- locally advanced or metastatic breast cancer (MBC): Clinical outcomes and stool microbial profiling.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback